Cite
HARVARD Citation
Champion, B. et al. (2015). Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Champion, B. et al. (2015). Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].